Skip to content

D&A at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$563M-0.7%
TFX
TeleflexTFX
$19.85M+52.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2B+13.1%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%
Edwards Lifesciences logo
Edwards LifesciencesEW
$40.9M+11.7%
Medtronic logo
MedtronicMDT
$716M-14.8%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's D&A?
Merit Medical Systems (MMSI) reported D&A of $30.5M in Q1 2026.
How has Merit Medical Systems's D&A changed year-over-year?
Merit Medical Systems's D&A increased by 4.1% year-over-year, from $29.29M to $30.5M.
What is the long-term trend for Merit Medical Systems's D&A?
Over 4 years (2021 to 2025), Merit Medical Systems's D&A has grown at a 10.0% compound annual growth rate (CAGR), from $84.07M to $123.17M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.